ISSUE 43 - NOV. 15, 2013PDF"Master Protocol" To Rely on Biomarkers In Testing Multiple Lung Cancer AgentsA new kind of clinical trial that will assign patients to therapy based on molecular characteristics of their disease is being launched by a coalition of government agencies, pharmaceutical companies, and a non-government organization.
In BriefLYNNE PENBERTHY was named associate director for surveillance research in NCI's Division of Cancer Control and Population Sciences.
In BriefLARRY KUN was named clinical director and executive vice president of St. Jude Children's Research Hospital.
Quality of CareASCO Publishes "Top Five"Ways to Improve Cancer CareThe American Society of Clinical Oncologypublished its second list of five opportunities to improve the quality and value of cancer care in the Journal of Clinical Oncology.
